Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Mahmud H, Fller M, Lang F
In pre-clinical models, BPC 157 has been observed to: Upregulate vascular endothelial growth factor (VEGF) , promoting new blood vessel formation in damaged tissue Modulate nitric oxide (NO) synthesis pathways, influencing vascular tone and healing cascades Interact with the growth hormone receptor system , potentially amplifying downstream tissue repair signaling Demonstrate cytoprotective effects along the gastrointestinal tract its native home territory as a gastric peptide Exhibit apparent neuroprotective properties in rodent models of CNS injury BPC 157 stability in gastric acid unusual for peptides has made it a focus of GI mucosal repair research
It is a dual agonist of GLP-1 and GIP receptors to help regulate blood sugar levels and reduce appetite to improve glycemic control and support weight loss in patients with chronic conditions
Studies have found that Megasphaera is a dominant genus of gut microbiota in different life stages of primates, and is also a key driving factor for the long-term development of gut microbiota in adults [72]
US$ 22.12
US$ 27.39
US$ 23.00
US$ 24.68
US$ 28.23
US$ 23.05
US$ 25.08
US$ 28.22
US$ 29.60
US$ 29.29
US$ 29.00
US$ 23.47
